Health Care & Life Sciences » Pharmaceuticals | Concordia International Corp.

Concordia International Corp.

Concordia International Corp.
Stock Exchange Toronto Stock Exchange Prices
EPS
CAD5495.62
Market Cap
CAD2.34 B
Shares Outstanding
51.28 M
Public Float
43.94 M

Profile

Address
277 Lakeshore Road East
Oakville Ontario L6H 1J9
Canada
Employees -
Website http://www.concordiarx.com
Updated 09/14/2018
Concordia International Corp. is a pharmaceutical company, which engages in owning and licensing a diversified portfolio of branded and generic prescription products. It operates through the Concordia North America and Concordia International segments. The Concordia North America segment focuses primarily on the United States pharmaceutical market and offers products under the brand of Donnatal, Zonegran, Nilandron, Lanoxin, Plaquenil, and Photofrin.

Financials

View All

Itzhak Krinsky
Chairman
Robert J. Manzo
Director